FRONTEO is a data analysis company that provides AI-powered solutions through its proprietary AI engine "KIBIT." The company's core offering is a natural language processing technology that analyzes text data and complex networks. KIBIT's AI engine has been integrated into KIBIT Automator (KAM), an analytics review tool for eDiscovery that can reduce document review time by approximately 50% compared to standard linear review. The technology assigns relevancy scores between 0 and 10,000 to documents and reorganizes them accordingly, creating a defensible cut-off point that reduces manual review requirements. In May 2024, FRONTEO obtained a US patent for its unique technology that solves natural language processing issues by maintaining the structural integrity of data from multiple specialized fields when integrated.
Key customers and partnerships
FRONTEO's customers span various sectors including legal, finance, government, and pharmaceutical industries. Asuka Pharmaceutical implemented FRONTEO's KIBIT Amanogawa system to enhance their drug discovery research and development processes. The system analyzes over 3 billion articles from PubMed to support pharmaceutical research. Springer Nature selected FRONTEO as a partner for developing AI drug discovery support services, combining PubMed article data with Springer Nature's journal database.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.